Article Versions Notes

Muhammed A, Fulgenzi CAM, Dharmapuri S, Pinter M, Balcar L, Scheiner B, Marron TU, Jun T, Saeed A, Hildebrand H, et al. The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma. Cancers. 2022; 14(1):186. https://doi.org/10.3390/cancers14010186

Muhammed, Ambreen, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U. Marron, Tomi Jun, Anwaar Saeed, Hannah Hildebrand, and et al. 2022. "The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma" Cancers 14, no. 1: 186. https://doi.org/10.3390/cancers14010186

Muhammed, A., Fulgenzi, C. A. M., Dharmapuri, S., Pinter, M., Balcar, L., Scheiner, B., Marron, T. U., Jun, T., Saeed, A., Hildebrand, H., Muzaffar, M., Navaid, M., Naqash, A. R., Gampa, A., Ozbek, U., Lin, J.-Y., Perone, Y., Vincenzi, B., Silletta, M., ... Pinato, D. J. (2022). The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma. Cancers, 14(1), 186. https://doi.org/10.3390/cancers14010186